Bank Julius Baer & Co’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.74M Buy
61,701
+1,754
+3% +$165K 0.01% 244
2026
Q1
$5.33M Buy
59,947
+2,254
+4% +$232K 0.02% 229
2025
Q4
$5.49M Sell
57,693
-4,329
-7% -$436K 0.02% 227
2025
Q3
$6.12M Sell
62,022
-2,690
-4% -$288K 0.02% 225
2025
Q2
$6.89M Buy
64,712
+3,482
+6% +$352K 0.02% 210
2025
Q1
$5.58M Buy
61,230
+4,550
+8% +$509K 0.02% 241
2024
Q4
$7.13M Buy
+56,680
New +$6.47M 0.02% 226
2023
Q2
Sell
-1,123
Closed -$140K 563
2023
Q1
$140K Sell
1,123
-353
-24% -$48.5K ﹤0.01% 463
2022
Q4
$222K Buy
+1,476
New +$227K ﹤0.01% 412
2022
Q1
Sell
-4,027
Closed -$1.04M 616
2021
Q4
$1.04M Sell
4,027
-89
-2% -$24.4K 0.01% 346
2021
Q3
$1.12M Buy
4,116
+51
+1% +$16.2K 0.01% 320
2021
Q2
$910K Buy
4,065
+2,702
+198% +$510K 0.01% 363
2021
Q1
$149K Buy
1,363
+774
+131% +$82.2K ﹤0.01% 582
2020
Q4
$48K Sell
589
-1,411
-71% -$139K ﹤0.01% 684
2020
Q3
$228K Sell
2,000
-800
-29% -$57.4K ﹤0.01% 485
2020
Q2
$188K Buy
+2,800
New +$140K ﹤0.01% 477

Other funds holding BNTX

Bank Julius Baer & Co's BNTX Position: Q2 2026 in Review

Bank Julius Baer & Co increased its BioNTech (BNTX) stake by 2.9% in Q2 2026, buying an estimated $165K and bringing the position to 61,701 shares worth $5.74M. The position accounts for 0.01% of the portfolio, ranked #244.

Bank Julius Baer & Co first reported a position in BNTX in Q2 2020 and has held it in 16 quarters since. The position peaked at $7.13M in Q4 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Bank Julius Baer & Co held 61,701 shares of BioNTech worth $5.74M as of Q2 2026.
  • Bank Julius Baer & Co bought 1,754 BioNTech shares in Q2 2026, an estimated $165K.
  • BioNTech made up 0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #244 holding.
  • Bank Julius Baer & Co first reported a position in BioNTech in Q2 2020 and has held it in 16 quarters since.
  • Bank Julius Baer & Co's BioNTech position peaked at $7.13M in Q4 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.